Gradual dose reduction, or GDR, is the planned, stepwise lowering of a psychiatric medication to find the lowest effective dose or to stop it safely. The term comes from federal nursing home regulations, which require facilities to attempt dose reductions of psychotropic medications, especially antipsychotics, at regular intervals unless clinically contraindicated, and to document the reasoning. The principle applies well beyond nursing homes. Any medication that has been taken for months should be reduced slowly rather than stopped abruptly, both to avoid withdrawal or discontinuation symptoms and to tell the difference between those symptoms and a true return of illness.
The pace depends on the drug. Benzodiazepines are typically reduced by 5 to 10 percent every two to four weeks, slower near the end. SSRIs and SNRIs with short half-lives, such as paroxetine and venlafaxine, need gradual steps over weeks to months to avoid dizziness, nausea and flu-like symptoms. Antipsychotics in older adults are reduced in stages with close observation for returning agitation or psychosis. Stimulants can usually be stopped quickly. Throughout a GDR, your provider tracks symptoms with rating scales and keeps the previous step available if the reduction is not tolerated. Stedfast Psychiatry performs GDRs in outpatient care and through our Stedfast Living program, which visits assisted living, independent living and skilled nursing facilities where regulatory review of antipsychotic use is routine and documentation requirements are specific.
Where this applies at Stedfast
- Psychiatric Medication Management
- Geriatric Psychiatry and the Stedfast Living Facility Program
- Psychiatric Services for Assisted Living and Skilled Nursing Facilities